Paul Streck - 04 Mar 2026 Form 4 Insider Report for PepGen Inc. (PEPG)

Role: EVP, Head of R&D
Signature: /s/ Noel Donnelly, as attorney-in-fact
Issuer symbol: PEPG
Transactions as of: 04 Mar 2026
Net transactions value: -$11,709
Form type: 4
Filing time: 06 Mar 2026, 16:14:09 UTC
Previous filing: 02 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
STRECK PAUL	EVP, Head of R&D	C/O PEPGEN INC., 321 HARRISON AVE., 8TH FL, BOSTON	/s/ Noel Donnelly, as attorney-in-fact	06 Mar 2026	0001708063

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PEPG	Common Stock	Sale	$11,413	-1,832	-2.3%	$6.23	76,273	04 Mar 2026	Direct	F1
transaction	PEPG	Common Stock	Sale	$296	-47	-0.06%	$6.29	76,226	04 Mar 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units ("RSUs"). The mandatory sale of the Reporting Person's shares was provided for in a RSU agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

Content

Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units ("RSUs"). The mandatory sale of the Reporting Person's shares was provided for in a RSU agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.